Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2542 of 5804
-
Live music may soothe Alzheimer's patients and caregivers, yale study hints
Symptom relief ENROLLING_BY_INVITATIONThis study aims to investigate the neurophysiological effects of live music on individuals with early Alzheimer's Disease (AD), dementia, and/or mild cognitive impairment (MCI) and their caregivers. Heart rate (HR), heart rate variability (HRV), and brain activity will be measure…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New pill could curb alcohol cravings, early trial hopes
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol craving in subjects with moderate to severe alcohol use disorder and these subjects are seeking treatment.
Phase: PHASE2 • Sponsor: Knoa Pharma LLC • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Can a single ketamine dose ease both pain and depression?
Symptom relief OngoingThe goal of this clinical trial is to compare ketamine to a placebo when given as a single infusion during IV sedation in adults with chronic pain and depression. We do not know whether ketamine will be more effective than placebo under these circumstances. This study aims to: …
Phase: PHASE4 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Could vitamin d and calcium help control gestational diabetes?
Disease control CompletedGestational diabetes mellitus (GDM) is becoming more common globally as a metabolic disease that occurs during pregnancy and influences the mother and the fetus. It has been linked to preeclampsia, C-section, and a higher lifetime risk of developing type 2 diabetes both for mothe…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Coaching clinics to spot At-Risk teens could save lives
Knowledge-focused Recruiting nowSuicide in youth is rapidly growing to where it is the second leading cause of death across the United States. Use of available tools have shown the potential to boost primary care providers' (PCPs) detection of suicide risk and confidence and knowledge around addressing it; howe…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Antibiotics or sugar pill? new study questions need for drugs in Kids' pneumonia
Symptom relief Recruiting nowThe goal of this clinical trial is to compare a placebo (a look-alike substance that contains no active drug) with a commonly used antibiotic in children with Mycoplasma pneumoniae (a specific bacterium) induced community-acquired pneumonia. The main question it aims to answer is…
Phase: NA • Sponsor: Christoph Berger • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New pill TQH3906 tested for tough gut diseases
Disease control Recruiting nowThis phase will commence following dose escalation in the 24mg bid group during Phase I. Employing a 1:1:1 randomized, double-blind, placebo-controlled study design, it will evaluate the efficacy, safety, and Pharmacokinetics/Pharmacodynamics (PK/PD) characteristics of TQH3906 ca…
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Home workouts tested as therapy for rare lung disease
Symptom relief Recruiting nowPulmonary arterial hypertension (PAH) is a rare and severe disease characterized by elevation of pulmonary artery pressure (PAP) and increased pulmonary vascular resistance (PVR) due to the narrowing of small pulmonary arteries. The European Society of Cardiology (ESC) and the Eu…
Phase: NA • Sponsor: Tampere Heart Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 15:53 UTC
-
Scientists hunt for genes behind rare bone tumor diseases
Knowledge-focused Recruiting nowBackground: Ollier disease (OD) and Maffucci syndrome (MS) are rare disorders that increase the risk of cancers in cartilage tissue. These tumors can lead to severe skeletal deformities beginning in childhood. People with OD or MS are also at an increased risk of blood vessel di…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI takes on rare brain tumors: a new hope for personalized care
Knowledge-focused Recruiting nowThis study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under the RARECARE definition of rare tumors. The main objective of the study is to sta…
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Virtual workouts could boost heart health in women
Symptom relief Recruiting nowThis study will compare the effects of two different types of training on exercise capacity in women with coronary heart disease (CHD). Participants will be randomized into either the virtual high-intensity interval training (HIIT) or the virtual moderate-to-vigorous intensity co…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Can a smartphone app boost sexual health after a stem cell transplant?
Symptom relief Recruiting nowThis research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem cell transplant survivors.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Brain zapping after magic mushrooms may lock in Life-Changing insights
Knowledge-focused Recruiting nowThis study will examine whether combining a single dose of psilocybin with non-invasive transcutaneous auricular vagus nerve stimulation (taVNS), a potential inducer of neuroplasticity and enhanced memory formation, will enhance the long-term beneficial behavioral effects of psil…
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Virtual physical therapy aims to ease back pain for rural patients
Symptom relief Recruiting nowPhysical therapy is the first line of treatment for patients with low back pain (LBP) and has been shown to be a cost-effective method for improving pain and disability in patients with chronic LBP; however, despite this effectiveness, only 7-13% of patients go on to receive phys…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Texts and peers aim to keep cancer survivors moving
Symptom relief Recruiting nowThe aim of this project is to help increase physical activity maintenance in cancer survivors.
Phase: NA • Sponsor: University of Tennessee • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can training entire clinics erase HIV stigma? new study aims to find out.
Knowledge-focused Recruiting nowThe scope of this study is to engage Ryan White HIV/AIDS Program (RWHAP) funded organizations in the South/East US to co-develop context-responsive programs utilizing evidence-informed interventions to reduce stigma against living with HIV (PLH) who have difficulties accessing an…
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New pill shows promise for keeping people with narcolepsy awake longer
Symptom relief Recruiting nowThe purpose of this study is to continue to measure the safety, tolerability, and durability of treatment effect in subjects with Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), or Idiopathic Hypersomnia (IH) when taking ALKS 2680 tablets.
Phase: PHASE2, PHASE3 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New hope for tough leukemia? early trial of ABBV-453 begins
Disease control OngoingChronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries. The purpose of this study is to assess how well ABBV-453 works adult participants with relapsed/refractory (R/R) untreated CLL/small lymphocytic lymphoma (SLL). Adverse events, pharmacokinetics, …
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Eating your way to a sharper mind: new study tests diet against dementia
Prevention Recruiting nowThis study intends to evaluate the feasibility and the effectiveness of an innovative and integrated nutrition-based intervention addressing key modifiable risk factors for dementia while meeting participants' preferences for nutrition-related sessions. The intervention will incl…
Phase: NA • Sponsor: Instituto de Saude Publica da Universidade do Porto • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Nerve block shows promise for Alzheimer's symptoms in small trial
Symptom relief CompletedThe goal of this clinical trial is to learn if ultrasound-guided stellate ganglion block (SGB), added to standard drug treatment, can improve thinking and memory in people with Alzheimer's disease. It will also learn about the safety of SGB. The main questions this study aims to…
Phase: NA • Sponsor: Taizhou Second People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC